Corpus ID: 56441176

Quality of life in ovarian cancer survivors

@inproceedings{Gonalves2015QualityOL,
  title={Quality of life in ovarian cancer survivors},
  author={V. Gonçalves},
  year={2015}
}
Ovarian cancer survivors may experience Quality of Life (QOL) disruptions due to the aggressiveness of the illness and its treatment. The present manuscript intends to review the most recent knowledge regarding QOL in ovarian cancer survivors. Firstly, a brief overview about QOL, their importance and instruments used to assess it particularly in ovarian cancer survivors are presented. Then, main findings and developments achieved to date are discussed. Main conclusions from studies reviewed and… Expand
Changes in health-related quality of life in older women after diagnosis with gynecologic cancer.
TLDR
Gynecologic cancer has significant impacts on physical and mental aspects of HRQOL in older women, and interventions are needed to reduce pain, provide support, and prepare patients for changes in functioning and health. Expand
Review of Rehabilitation Programs for Cancer survivors
TLDR
This study sought to determine the content and structure of rehabilitation programs for cancer survivors, analyze the effectiveness of such programs, and develop a basis for future comprehensive rehabilitation program development. Expand
Depression level and quality of life in ovarian cancer patients in Zainoel Abidin Hospital, Banda Aceh
TLDR
There is a significant relationship between depression and quality of life in ovarian cancer patients who are undergoing chemotherapy in RSUDZA Banda Aceh and this study was an analytical observa-tional study with cross-sectional design approach. Expand

References

SHOWING 1-10 OF 36 REFERENCES
Determinants of quality of life in ovarian cancer survivors: a pilot study.
TLDR
In women with ovarian cancer, clinical factors such as age, stage, and histology did not have a significant impact on quality of life (QoL) and Psychosocial factors have a larger impact on global QoL than physical symptoms. Expand
Quality of Life Considerations in Gynecologic Cancer
  • R. Penson, L. Wenzel, I. Vergote, D. Cella
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2006
TLDR
The QOL issues facing gynecologic cancer patients, the use of validated QOL instruments, recent advances in the evaluation of interventions, and changes in concepts related to QOL are reviewed. Expand
Long-term adjustment of early-stage ovarian cancer survivors
TLDR
Early-stage ovarian cancer survivors had few physical complaints and unmet needs, but psychologic distress was evident in a subset of survivors; the majority of survivors reported sexual dysfunction. Expand
Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
  • R. Penson, L. Wenzel, I. Vergote, D. Cella
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2006
TLDR
The QOL issues facing gynecologic cancer patients, the use of validated QOL instruments, recent advances in the evaluation of interventions, and changes in concepts related to QOL are reviewed. Expand
State of the Science in Ovarian Cancer Quality of Life Research: A Systematic Review
TLDR
There is a need to enhance the standardized collection and reporting of HRQOL data from research involving women with ovarian cancer so that research can build on the cumulative knowledge base to improve outcomes in this patient population. Expand
Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
TLDR
Regardless of staging, OCS experience similarly overall positive QOL and adjustment, though PTSD, sexual problems and fear of recurrence are still important for some survivors. Expand
Health-related quality of life in ovarian cancer patients and its impact on clinical management
  • D. Chase, L. Wenzel
  • Medicine
  • Expert review of pharmacoeconomics & outcomes research
  • 2011
TLDR
The state of the science of HRQOL measurement in clinical trial design and outcomes is highlighted and symptom management in ovarian cancer and its ability to modulate quality of life will be explored. Expand
Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study
TLDR
Results indicate that this disease‐free early‐stage sample enjoys a good QOL, with physical, emotional, and social well‐being comparable to other survivors and same‐aged noncancer cohorts, however, 20% of survivors indicated the presence of long‐term treatment side effects, with a subset reporting problems related to abdominal and gynecologic symptoms, and neurotoxicity. Expand
Quality of life research in head and neck cancer: a review of the current state of the science.
TLDR
In general, QOL declines immediately after therapy and returns toward baseline by 1 year, and several factors have been identified that may predict for worse QOL outcomes including: the presence of a feeding tube, co-morbid disease, tracheotomy, site and stage. Expand
Prospective assessment of quality of life in long‐term ovarian cancer survivors
TLDR
It is found that long‐term ovarian cancer patients have QoL scores similar to females without a history of cancer, and the presence of intra operative ascites and a supporting social network were identified as significant variables that discriminated between short‐term and long-term survival. Expand
...
1
2
3
4
...